Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 67


Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H.

Breast Cancer Res Treat. 2016 Oct 22.


How Do Intensity and Duration of Rehabilitation Services Affect Outcomes From Severe Traumatic Brain Injury? A Natural Experiment Comparing Health Care Delivery Systems in 2 Developed Nations.

Hart T, Whyte J, Poulsen I, Kristensen KS, Nordenbo AM, Chervoneva I, Vaccaro MJ.

Arch Phys Med Rehabil. 2016 Aug 3. pii: S0003-9993(16)30381-1. doi: 10.1016/j.apmr.2016.07.012.


An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma.

Teh JL, Purwin TJ, Greenawalt EJ, Chervoneva I, Goldberg A, Davies MA, Aplin AE.

Cancer Res. 2016 Sep 15;76(18):5455-66. doi: 10.1158/0008-5472.CAN-15-3384.


RhoA inhibits neural differentiation in murine stem cells through multiple mechanisms.

Yang J, Wu C, Stefanescu I, Jakobsson L, Chervoneva I, Horowitz A.

Sci Signal. 2016 Jul 26;9(438):ra76. doi: 10.1126/scisignal.aaf0791.


Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.

Mod Pathol. 2016 Oct;29(10):1143-54. doi: 10.1038/modpathol.2016.112.


Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers.

Nagalla S, Thomson L, Oppong Y, Bachman B, Chervoneva I, Kraft WK.

Clin Transl Sci. 2016 Jun;9(3):176-80. doi: 10.1111/cts.12398.


Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes.

Oppong YD, Farber JL, Chervoneva I, Martinez Cantarin MP.

Clin Transplant. 2016 Jul;30(7):836-44. doi: 10.1111/ctr.12757.


Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein.

Mintzer S, Miller R, Shah K, Chervoneva I, Nei M, Skidmore C, Sperling MR.

Epilepsy Behav. 2016 May;58:127-32. doi: 10.1016/j.yebeh.2016.02.023.


The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.

Salem I, Alsalahi M, Chervoneva I, Aburto LD, Addya S, Ott GR, Ruggeri BA, Cristofanilli M, Fernandez SV.

Breast Cancer Res. 2016 Mar 24;18(1):37. doi: 10.1186/s13058-016-0694-4.


Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.

Terai M, Mu Z, Eschelman DJ, Gonsalves CF, Kageyama K, Chervoneva I, Orloff M, Weight R, Mastrangelo MJ, Cristofanilli M, Sato T.

EBioMedicine. 2015 Sep 18;2(11):1821-6. doi: 10.1016/j.ebiom.2015.09.019.


Changes in the preferences of US physicians-in-training for medical interventions throughout medical education.

Valentino MA, Chervoneva I, Diemer GA.

Med Educ. 2016 Feb;50(2):214-24. doi: 10.1111/medu.12938.


Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year After Moderate to Severe Traumatic Brain Injury.

Hart T, Fann JR, Chervoneva I, Juengst SB, Rosenthal JA, Krellman JW, Dreer LE, Kroenke K.

Arch Phys Med Rehabil. 2016 May;97(5):701-7. doi: 10.1016/j.apmr.2015.08.436.


ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.

Capparelli C, Rosenbaum S, Berman-Booty LD, Salhi A, Gaborit N, Zhan T, Chervoneva I, Roszik J, Woodman SE, Davies MA, Setiady YY, Osman I, Yarden Y, Aplin AE.

Cancer Res. 2015 Sep 1;75(17):3554-67. doi: 10.1158/0008-5472.CAN-14-2959.


Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

Valsecchi ME, Terai M, Eschelman DJ, Gonsalves CF, Chervoneva I, Shields JA, Shields CL, Yamamoto A, Sullivan KL, Laudadio M, Berd D, Mastrangelo MJ, Sato T.

J Vasc Interv Radiol. 2015 Apr;26(4):523-32.e2. doi: 10.1016/j.jvir.2014.11.037.


A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.

Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK.

Am J Cancer Ther Pharmacol. 2014 Sep 7;2(1):21-32.


A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.

Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N.

Biol Blood Marrow Transplant. 2015 Apr;21(4):646-52. doi: 10.1016/j.bbmt.2014.12.019.


Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.

Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H.

Breast Cancer Res. 2013;15(5):R73.


Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty.

Mraovic B, Hipszer BR, Epstein RH, Parvizi J, Pequignot EC, Chervoneva I, Joseph JI.

Croat Med J. 2013 Aug;54(4):355-61.


Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.

Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H.

Oncogene. 2014 Apr 24;33(17):2215-24. doi: 10.1038/onc.2013.172.

Items per page

Supplemental Content

Loading ...
Support Center